Center for Scientific Review; Notice of Closed Meetings, 56475-56476 [2015-23387]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 181 / Friday, September 18, 2015 / Notices
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Marcy Ellen Burstein,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6143, MSC 9606,
Bethesda, MD 20892–9606, 301–443–9699,
bursteinme@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel.
Date: October 14, 2015.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Marcy Ellen Burstein,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6143, MSC 9606,
Bethesda, MD 20892–9606, 301–443–9699,
bursteinme@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: September 14, 2015.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–23445 Filed 9–17–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health Notice of Meeting
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Advisory Committee on Research on
Women’s Health.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Advisory Committee
on Research on Women’s Health.
Date: October 20, 2015.
Open: 9:00 a.m. to 12:00 p.m.
Agenda: The Committee serves to advise
and make recommendations to the Director,
Office of Research on Women’s Health
(ORWH) on a broad range of topics.
Place: National Institutes of Health, Wilson
Hall, Building 1, 1 Center Drive, Bethesda,
MD 20892.
Open: 1:00 p.m. to 5:00 p.m.
Agenda: ORWH 25th Anniversary
Celebration of Science.
VerDate Sep<11>2014
18:47 Sep 17, 2015
Jkt 235001
Place: National Institutes of Health, Wilson
Hall, Building 1, 1 Center Drive, Bethesda,
MD 20892.
Contact Person: Terri L. Cornelison, MD,
Ph.D., Executive Secretary, Office of Research
on Women’s Health, Office of the Director,
National Institutes of Health, 6707
Democracy Blvd., Bethesda, MD 20817, (301)
402–1770, terri.conelison@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
www4.od.nih.gov/orwh/, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: September 14, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Police.
[FR Doc. 2015–23385 Filed 9–17–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
56475
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Sleep and Circadian Processes.
Date: October 13–14, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: John Bishop, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Cancer Biomarkers Study Section.
Date: October 13–14, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Lawrence Ka-Yun Ng,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152,
MSC 7804, Bethesda, MD 20892, 301–357–
9318, ngkl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Epilepsy and Neurodegenerative
Diseases.
Date: October 14, 2015.
Time: 12:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Seetha Bhagavan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 237–
9838, bhagavas@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Drug Discovery and Mechanisms of
Antimicrobial Resistance Study Section.
Date: October 15–16, 2015.
Time: 8:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Guangyong Ji, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3188,
MSC 7808, Bethesda, MD 20892, 301–435–
1146, jig@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR15–162:
Pilot Clinical Urology.
Date: October 22, 2015.
Time: 4:00 p.m. to 5:00 p.m.
E:\FR\FM\18SEN1.SGM
18SEN1
56476
Federal Register / Vol. 80, No. 181 / Friday, September 18, 2015 / Notices
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Washington National
Airport, 1489 Jefferson Davis Hwy, Arlington,
VA 22202.
Contact Person: Ryan G Morris, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4205,
MSC 7814, Bethesda, MD 20892, 301–435–
1501, morrisr@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 14, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–23387 Filed 9–17–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Muscular Dystrophy Coordinating
Committee (MDCC).
The meeting will be open to the
public and accessible by live webcast.
Name of Committee: Muscular Dystrophy
Coordinating Committee.
Type of meeting: Open Meeting.
Date: November 13, 2015.
Time: 8:30 a.m. to 4:30 p.m. *Eastern
Time*—Approximate end time.
Agenda: The purpose of this meeting is to
bring together committee members,
representing government agencies, patient
advocacy groups, other voluntary health
organizations, and patients and their families
to update one another on progress relevant to
the Action Plan for the Muscular Dystrophies
and to coordinate activities and discuss gaps
and opportunities leading to better
understanding of the muscular dystrophies,
advances in treatments, and reduced disease
burden. Prior to the meeting, an agenda will
be posted to the MDCC meeting registration
Web site: https://meetings.ninds.nih.gov/
meetings/MDCC13Nov2015/.
Registration: To register, please go to:
https://meetings.ninds.nih.gov/meetings/
MDCC13Nov2015/.
Webcast Live: For those not able to attend
in person, this meeting will be webcast at:
https://videocast.nih.gov/.
Place: Neuroscience Center, Conference
Room C/D, 6001 Executive Boulevard,
Rockville, Maryland 20852.
Contact Person: Glen H. Nuckolls, Ph.D.,
Executive Secretary, Muscular Dystrophy
VerDate Sep<11>2014
19:33 Sep 17, 2015
Jkt 235001
Coordinating Committee, National Institute
of Neurological Disorders and Stroke, NIH,
6001 Executive Boulevard, NSC 2203,
Rockville, MD 20852, (301) 496–5739,
glen.nuckolls@ninds.nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Attendance is limited to seating space
available. Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other reasonable
accommodations, should inform the Contact
Person listed above in advance of the
meeting. All visitors must go through a
security check at the meeting site to receive
a visitor’s badge. A valid, government issued
photo ID must be presented before a visitor’s
badge can be issued. Further information can
be found at the registration Web site:
https://meetings.ninds.nih.gov/meetings/
MDCC13Nov2015/.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: September 14, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–23443 Filed 9–17–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
In Vitro to In Vivo Extrapolation for
High Throughput Prioritization and
Decision Making; Notice of Webinars
and Public Workshop; Registration
Information
The National Toxicology
Program (NTP) Interagency Center for
the Evaluation of Alternative
Toxicological Methods (NICEATM) and
the U.S. Environmental Protection
Agency (EPA) announce the workshop,
‘‘In Vitro to In Vivo Extrapolation for
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
High Throughput Prioritization and
Decision Making.’’ Attendees at the inperson workshop and four webinar
presentations leading up to the
workshop will discuss the state of the
science and best practices for using in
vitro to in vivo extrapolation (IVIVE) in
a tiered risk decision context.
DATES: Webinars: October 7, 2015, at
11:00 a.m. Eastern Daylight Time (EDT);
and November 4, 2015; December 2,
2015; and January 6, 2016; at 11:00 a.m.
Eastern Standard Time (EST).
Webinar Registration: Deadline is two
business days prior to each webinar.
Workshop: February 17–18, 2016,
from 9:00 a.m. to approximately 5:00
p.m. (EST).
Workshop Registration: Deadline is
February 5, 2016 at 5:00 p.m. (EST).
ADDRESSES:
Workshop Location: U.S.
Environmental Protection Agency, 109
T.W. Alexander Dr., Durham, NC,
27709.
Web page: The preliminary agenda,
registration, and other meeting materials
will be available at https://
ntp.niehs.nih.gov/go/ivive-wksp-2016.
FOR FURTHER INFORMATION CONTACT: Dr.
Warren S. Casey, Director, NICEATM;
email: warren.casey@nih.gov; telephone:
(919) 316–4729.
SUPPLEMENTARY INFORMATION:
Background: Data from high
throughput in vitro tests are being
generated for many chemicals of
environmental and commercial interest,
with the expectation that in vitro assay
data could ultimately be used to predict
adverse effects of chemical exposures in
vivo. Translating values obtained from
in vitro assays into estimates of in vivo
outcomes is a complex process
involving the use of mathematical
modeling and increasingly complex test
systems. The series of four webinars and
in-person workshop aim to address the
capabilities and limitations of IVIVE
within the context of risk decisionmaking.
The webinar series will present the
current science, and the in-person
workshop will facilitate discussions that
follow-up and build on information
presented in the webinars. During the
workshop, participants will (1) review
the state of the science to form
recommendations on best practices for
using IVIVE in chemical screening and
risk-based decision making, (2) identify
areas that require additional data and/or
research, and (3) highlight examples of
how best to apply IVIVE in a tiered risk
decision-making strategy.
Preliminary Agenda and Other
Meeting Information: A preliminary
agenda and additional information will
E:\FR\FM\18SEN1.SGM
18SEN1
]]>Agencies
[Federal Register Volume 80, Number 181 (Friday, September 18, 2015)]
[Notices]
[Pages 56475-56476]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-23387]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Sleep and Circadian Processes.
Date: October 13-14, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John Bishop, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408-
9664, bishopj@csr.nih.gov.
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Cancer Biomarkers Study Section.
Date: October 13-14, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Lawrence Ka-Yun Ng, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152, MSC 7804, Bethesda, MD
20892, 301-357-9318, ngkl@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Epilepsy and Neurodegenerative Diseases.
Date: October 14, 2015.
Time: 12:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Seetha Bhagavan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD
20892, (301) 237-9838, bhagavas@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group; Drug Discovery and Mechanisms of
Antimicrobial Resistance Study Section.
Date: October 15-16, 2015.
Time: 8:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Guangyong Ji, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3188, MSC 7808, Bethesda, MD 20892, 301-435-
1146, jig@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR15-162: Pilot Clinical Urology.
Date: October 22, 2015.
Time: 4:00 p.m. to 5:00 p.m.
[[Page 56476]]
Agenda: To review and evaluate grant applications.
Place: Crowne Plaza Washington National Airport, 1489 Jefferson
Davis Hwy, Arlington, VA 22202.
Contact Person: Ryan G Morris, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4205, MSC 7814, Bethesda, MD 20892, 301-435-
1501, morrisr@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 14, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-23387 Filed 9-17-15; 8:45 am]
BILLING CODE 4140-01-P
